CTOs on the Move

CliniComp

www.clinicomp.com

 
CliniComp is a global provider of Electronic Health Record (EHR) software and solutions that has enjoyed an unrivaled track record of performance and reliability in the most complex high acuity hospital environments for decades. Starting in 2014 CliniComp EHR extends the scope of coverage to Outpatient and Ancillaries such as Pharmacy, Radiology, and clinical laboratory information systems. This fully-integrated one stop expanded offering guarantees seamless CPOE and order/results management as well as transparent patient record viewing across all patient environments, distinct sites and time. Every Patient. Everywhere. For Life. The CCI system is certified for Stage 2 Meaningful Use and ...
  • Number of Employees: 100-250
  • Annual Revenue: $10-50 Million

Executives

Name Title Contact Details

Similar Companies

Contemporary Life Saving Training

Contemporary Life Saving Training is a O Fallon, IL-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

AcelRx

AcelRx Pharmaceuticals Inc. is a specialty pharmaceutical company focused on the development and commercialization of innovative therapies for the treatment of moderate-to-severe acute pain. The Company`s product candidates, DSUVIA™ (known as ARX-04 outside of the United States) and ZALVISO®, are designed to deliver sufentanil, a strong opioid analgesic, via a non-invasive, sublingual formulation in medical supervised settings. DSUVIA is designed to deliver sublingual tablets containing 30 mcg sufentanil via a disposable, pre-filled, single-dose applicator. The Phase 3 clinical program has completed and assessed the investigational product in the treatment of moderate-to-severe acute pain in patients who had undergone surgery or who presented to an emergency room with trauma or injury. In clinical studies, DSUVIA demonstrated reductions in pain intensity as early as 15-to-30 minutes after the start of dosing and the most common adverse events included nausea, headache, dizziness, and vomiting. A New Drug Application (NDA) was filed with the FDA in December 2016. ZALVISO is designed to deliver sublingual tablets containing 15 mcg sufentanil via a novel hand-held, pre-programmed, patient-controlled analgesia system. Three Phase 3 clinical trials have been completed in patients who had undergone major abdominal or orthopedic surgeries. A fourth study (IAP312) is underway to further evaluate the overall performance of the ZALVISO System in post-surgical patients. ZALVISO is currently approved by the European Commission for the management of acute moderate-to-severe post-operative pain in adult patients in a hospital setting, and is marketed by Grünenthal Group, AcelRx`s licensee in Europe and Australia. In the United States and other geographies, ZALVISO remains an investigational product.

InfoQuest Clinical Network Inc

InfoQuest Clinical Network Inc is a Alvarado, TX-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Palodex

PaloDEx Group Oy operates in the international healthcare market, focusing on X-ray technology applications used in dental imaging. By offering high-quality imaging solutions that help in making the correct treatment decisions and in improving the level

Medical Center Enterprise

Medical Center Enterprise is a Enterprise, AL-based company in the Healthcare, Pharmaceuticals, and Biotech sector.